Targeting Neoantigens in Glioblastoma: An Overview of Cancer Immunogenomics and Translational Implications.

about

Targeting Neoantigens in Glioblastoma: An Overview of Cancer Immunogenomics and Translational Implications.

Item

http://www.wikidata.org/entity/Q50130464

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Targeting Neoantigens in Gliob ...... nd Translational Implications.

@en

Targeting Neoantigens in Gliob ...... nd Translational Implications.

@nl

type

Item

label

Targeting Neoantigens in Gliob ...... nd Translational Implications.

@en

Targeting Neoantigens in Gliob ...... nd Translational Implications.

@nl

prefLabel

Targeting Neoantigens in Gliob ...... nd Translational Implications.

@en

Targeting Neoantigens in Gliob ...... nd Translational Implications.

@nl

P1476

Targeting Neoantigens in Gliob ...... and Translational Implications

@en

P2093

Connor Liu

http://www.w3.org/2001/XMLSchema#string

Gavin P Dunn

http://www.w3.org/2001/XMLSchema#string

Jay A Bowman-Kirigin

http://www.w3.org/2001/XMLSchema#string

Tanner M Johanns

http://www.w3.org/2001/XMLSchema#string

P2860

IDH1 and IDH2 mutations in gliomas

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Clearance systems in the brain-implications for Alzheimer disease

A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules

Structural and functional features of central nervous system lymphatic vessels.

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.

Tumor neoantigens: building a framework for personalized cancer immunotherapy

Cancer immunoediting: from immunosurveillance to tumor escape

P304

165-176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUROS/NYX321

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

CN_suppl_1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28899059

http://www.w3.org/2001/XMLSchema#string

P932

6287409

http://www.w3.org/2001/XMLSchema#string